• Home
  • Pharmacist Continuing Education - Immunotherapy and Management of Immune-Related Adverse Effects: A Focus on the Immune Checkpoint Inhibitors

Pharmacist Continuing Education - Immunotherapy and Management of Immune-Related Adverse Effects: A Focus on the Immune Checkpoint Inhibitors

  • 06 Jun 2018
  • 06 Sep 2018

Immunotherapy and Management of Immune-Related Adverse Effects: A Focus on the Immune Checkpoint Inhibitors

Authors: Mallory Crain, PharmD: PGY-2 Oncology Resident Barnes-Jewish Hospital and Sara K. Butler, PharmD, BCPS, BCOP: Barnes-Jewish Hospital

Program Number: 2018-04-10
Approval Dates: 6/6/18 - 9/6/18
Approved Contact Hours: One (1) CE(s) per LIVE session.

Objectives
Understand the general mechanism of immune checkpoint inhibitors and specific mechanisms of action for the individual agents.

  1. Identify immune checkpoint inhibitor agents, mechanism of action, FDA-approved indications, and dosing.
  2. Recognize common immune-related adverse effects and factors that increase patient’s risk of developing immune-related adverse effects.
  3. Identify management strategies for common immune-related adverse effects including cutaneous, gastrointestinal, endocrine, and pulmonary toxicities.
  4. Recommend monitoring and supportive care measures for medications initiated to manage immune-related adverse effects.


Read the Article and Submit for CE

Copyright 2017, Missouri Society of Health-System Pharmacists
501(c)6 non-profit organization. 2650 S. Hanley Rd., Suite 100, St. Louis, MO 63144
p: 314-416-2246, f: 314-845-1891, www.moshp.org
Powered by Wild Apricot Membership Software